Uncommon Side Effects of Sunitinib Therapy in a Patient with Metastatic Renal Cell Cancer: Case Report

Sunitinib is an orally administered multikinase inhibitor. This therapy can provoke uncommon side effects such as pancytopenia, tumor lysis syndrome, cardiac disorders, thromboembolic incidents, intestinal perforation, pancreatitis, acute renal failure, etc. We report a case of a 63-year-old female...

全面介紹

書目詳細資料
Main Authors: Robert Šeparović, Mirjana Pavlović, Tajana Silovski, Hrvoje Silovski, Ana Tečić Vuger
格式: Article
語言:English
出版: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2018-01-01
叢編:Acta Clinica Croatica
主題:
在線閱讀:https://hrcak.srce.hr/file/315460